ABCC3 and hepatotoxicity: The occurrence of ABCC3‐1767GA was almost similar in tobacco using HIV patients without hepatotoxicity compared with nonusers (27.9% vs. 28.4%, OR = 1.03, 95% CI: 0.42–2.50, p = .88).